Published in J Inherit Metab Dis on October 10, 2009
Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis (2010) 1.28
Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects. J Inherit Metab Dis (2011) 0.98
Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation. J Inherit Metab Dis (2013) 0.84
Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia. J Bioenerg Biomembr (2011) 0.82
Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist. Pediatr Nephrol (2012) 0.80
Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child (1967) 2.56
Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol (2003) 1.69
Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res (2007) 1.44
Methylmalonicacidemia: biochemical heterogeneity in defects of 5'-deoxyadenosylcobalamin synthesis. Proc Natl Acad Sci U S A (1975) 1.39
Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem (2002) 1.27
Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J (2006) 1.23
Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach. J Inherit Metab Dis (2007) 1.22
Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis (1993) 1.19
Mapping of human methylmalonyl CoA mutase (MUT) locus on chromosome 6. Am J Hum Genet (1988) 1.14
Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis (2008) 1.13
Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem (2005) 1.09
Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res (1975) 1.07
Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr (1991) 1.04
Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res (2009) 1.04
Porphyrin accumulation in mitochondria is mediated by 2-oxoglutarate carrier. J Biol Chem (2006) 1.02
Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet (2007) 1.01
Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem (2003) 0.99
The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria. A possible explantation for hypoglycemia in methylmalonic aciduria. J Clin Invest (1971) 0.94
Molecular studies in mutase-deficient (MUT) methylmalonic aciduria: identification of five novel mutations. Hum Mutat (2002) 0.83
Methylmalonic acid--an endogenous toxin? Cell Mol Life Sci (2005) 0.82
Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria. J Clin Invest (1990) 0.82
Identification and perturbation of mutant human fibroblasts based on measurements of methylmalonic acid and total homocysteine in the culture media. Arch Biochem Biophys (1993) 0.81
Inhibition of vitamin B12 metabolism by OH-cobalamin c-lactam in rat oligodendrocytes in culture: a model for studying neuropathy due to vitamin B12 deficiency. Neurosci Lett (2000) 0.79
Hydroxycobalamin[c-lactam] increases total coenzyme A content in primary culture hepatocytes by accelerating coenzyme A biosynthesis secondary to Acyl-CoA accumulation. J Nutr (1993) 0.75
Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 1.41
Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis (2007) 1.31
Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach. J Inherit Metab Dis (2007) 1.22
Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand (2012) 1.11
Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice). Neurochem Int (2007) 1.08
Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol (1995) 0.99
A single external enzyme confers alternative NADH:ubiquinone oxidoreductase activity in Yarrowia lipolytica. J Cell Sci (1999) 0.99
Neonatal screening for glutaric aciduria type I: strategies to proceed. J Inherit Metab Dis (2006) 0.97
Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis (2009) 0.94
Role of deprotonation events in ubihydroquinone:cytochrome c oxidoreductase from bovine heart and yeast mitochondria. Biochemistry (1997) 0.94
Maintenance treatment of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.93
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism. J Inherit Metab Dis (2008) 0.92
Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.92
Newborn screening for methylmalonic acidurias--optimization by statistical parameter combination. J Inherit Metab Dis (2008) 0.92
Three molecules of ubiquinone bind specifically to mitochondrial cytochrome bc1 complex. J Biol Chem (2001) 0.91
Abnormal sterol metabolism in holoprosencephaly: studies in cultured lymphoblasts. J Med Genet (2007) 0.90
Oral health status of adults from a California regional center for developmental disabilities. Spec Care Dentist (2001) 0.89
Diagnostic work-up and management of patients with isolated methylmalonic acidurias in European metabolic centres. J Inherit Metab Dis (2008) 0.88
Looking beyond the basal ganglia: the spectrum of MRI changes in methylmalonic acidaemia. J Inherit Metab Dis (2008) 0.87
3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. J Neurosci Res (2001) 0.86
Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics (2003) 0.85
Reduction of lysine intake while avoiding malnutrition--major goals and major problems in dietary treatment of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.85
Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology (2005) 0.84
Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis (2009) 0.84
Nutritional indicators of postburn bacteremic sepsis. JPEN J Parenter Enteral Nutr (1982) 0.84
Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism. Horm Metab Res (2005) 0.83
Methylmalonic acid--an endogenous toxin? Cell Mol Life Sci (2005) 0.82
Measurement of bile acid CoA esters by high-performance liquid chromatography-electrospray ionisation tandem mass spectrometry (HPLC-ESI-MS/MS). J Mass Spectrom (2005) 0.82
Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res (2001) 0.82
Fluid retention during the first 48 hours as an indicator of burn survival. J Trauma (1986) 0.80
Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases. Ann Rheum Dis (2001) 0.80
Animal models for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.79
Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.79
Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up. Mol Genet Metab (2013) 0.77
Looking forward--an evidence-based approach to glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.76
Intracellular cAMP and beta 2-adrenergic receptors on CD19+ lymphocytes in patients with rheumatoid arthritis. Ann N Y Acad Sci (1999) 0.76
Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missed diagnosis? Neurology (2006) 0.76
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology (2003) 0.75
Gamma-hydroxybutyric acid sedation in neonates and children undergoing MR imaging. Klin Padiatr (2007) 0.75
Derivation of serum transferrin. JAMA (1981) 0.75
Comparison of derived and actual transferrin: a potential source of error in clinical nutritional assessment. J Trauma (1981) 0.75
Acrodermatitis acidaemia secondary to 'overtreatment' and protein deficiency. J Inherit Metab Dis (2006) 0.75
Challenges for basic research in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.75